{
    "Trade/Device Name(s)": [
        "ARCHITECT SHBG"
    ],
    "Submitter Information": "Biokit S.A.",
    "510(k) Number": "K152185",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060818"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "CDZ"
    ],
    "Summary Letter Date": "December 10, 2015",
    "Summary Letter Received Date": "December 14, 2015",
    "Submission Date": "February 1, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.1680"
    ],
    "Regulation Name(s)": [
        "Testosterone test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Sex hormone binding globulin (SHBG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT SHBG chemiluminescent immunoassay for quantitative SHBG determination in human serum and plasma.",
    "Indications for Use Summary": "A chemiluminescent microparticle immunoassay for quantitative determination of sex hormone binding globulin in human serum and plasma as an aid in the diagnosis of androgen disorders.",
    "fda_folder": "Clinical Chemistry"
}